Manulife (Manufacturers Life Insurance)
BIIB icon

Manulife (Manufacturers Life Insurance)’s Biogen BIIB Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.4M Sell
95,108
-10,628
-10% -$1.96M 0.02% 648
2025
Q4 		$18.6M Sell
105,736
-15,115
-13% -$2.47M 0.02% 661
2025
Q3 		$16.9M Buy
120,851
+13,098
+12% +$1.77M 0.01% 682
2025
Q2 		$13.5M Sell
107,753
-11,503
-10% -$1.43M 0.01% 727
2025
Q1 		$16.3M Sell
119,256
-4,410
-4% -$630K 0.02% 662
2024
Q4 		$18.9M Buy
123,666
+122
+0.1% +$20.6K 0.02% 644
2024
Q3 		$23.9M Sell
123,544
-2,285
-2% -$478K 0.02% 578
2024
Q2 		$29.2M Sell
125,829
-6,596
-5% -$1.43M 0.03% 504
2024
Q1 		$28.6M Sell
132,425
-2,751
-2% -$644K 0.03% 512
2023
Q4 		$35M Buy
135,176
+6,980
+5% +$1.71M 0.02% 457
2023
Q3 		$32.9M Buy
128,196
+14,668
+13% +$3.92M 0.02% 442
2023
Q2 		$32.3M Sell
113,528
-10,981
-9% -$3.27M 0.02% 442
2023
Q1 		$34.6M Sell
124,509
-4,204
-3% -$1.16M 0.02% 432
2022
Q4 		$35.6M Sell
128,713
-32,808
-20% -$9.27M 0.02% 414
2022
Q3 		$43.1M Sell
161,521
-2,313
-1% -$491K 0.03% 359
2022
Q2 		$33.4M Sell
163,834
-2,990
-2% -$611K 0.02% 424
2022
Q1 		$35.1M Buy
166,824
+54,301
+48% +$11.8M 0.02% 459
2021
Q4 		$27K Sell
112,523
-20,993
-16% -$5.4M 0.02% 551
2021
Q3 		$37.8M Sell
133,516
-13,519
-9% -$4.43M 0.03% 447
2021
Q2 		$50.9M Sell
147,035
-2,480
-2% -$751K 0.04% 369
2021
Q1 		$41.8M Buy
149,515
+7,838
+6% +$2.11M 0.04% 408
2020
Q4 		$34.7M Sell
141,677
-7,337
-5% -$1.89M 0.03% 424
2020
Q3 		$42.3M Sell
149,014
-29,079
-16% -$8.11M 0.04% 356
2020
Q2 		$46.4M Sell
178,093
-18,139
-9% -$5.45M 0.04% 325
2020
Q1 		$62.1M Buy
196,232
+26,782
+16% +$8.13M 0.07% 256
2019
Q4 		$50.3M Sell
169,450
-520,247
-75% -$144M 0.05% 318
2019
Q3 		$159M Sell
689,697
-18,181
-3% -$4.23M 0.18% 139
2019
Q2 		$166M Buy
707,878
+26,804
+4% +$6.19M 0.19% 128
2019
Q1 		$161M Buy
681,074
+112
+0% +$35.3K 0.17% 140
2018
Q4 		$205M Sell
680,962
-49,597
-7% -$15.8M 0.26% 101
2018
Q3 		$258M Sell
730,559
-65,415
-8% -$22.5M 0.27% 79
2018
Q2 		$231M Buy
795,974
+84,467
+12% +$23.7M 0.25% 94
2018
Q1 		$195M Buy
711,507
+939
+0.1% +$291K 0.22% 114
2017
Q4 		$226M Sell
710,568
-12,001
-2% -$3.85M 0.24% 98
2017
Q3 		$226M Buy
722,569
+16,571
+2% +$4.91M 0.27% 90
2017
Q2 		$192M Buy
705,998
+6,437
+0.9% +$1.7M 0.23% 100
2017
Q1 		$191M Buy
699,561
+33,057
+5% +$9.35M 0.24% 105
2016
Q4 		$174M Sell
666,504
-44,065
-6% -$13.1M 0.25% 103
2016
Q3 		$222M Sell
710,569
-546
-0.1% -$162K 0.33% 79
2016
Q2 		$172M Buy
711,115
+22,919
+3% +$6.04M 0.26% 97
2016
Q1 		$175M Sell
688,196
-27,054
-4% -$7.15M 0.15% 109
2015
Q4 		$219K Sell
715,250
-29,697
-4% -$8.53M 0.21% 83
2015
Q3 		$217K Buy
744,947
+169,782
+30% +$56.1M 0.23% 86
2015
Q2 		$232K Buy
575,165
+35,057
+6% +$14.1M 0.28% 73
2015
Q1 		$228K Sell
540,108
-29,221
-5% -$11.5M 0.29% 68
2014
Q4 		$193K Sell
569,329
-17,505
-3% -$5.66M 0.28% 80
2014
Q3 		$194K Buy
586,834
+36,490
+7% +$12M 0.29% 70
2014
Q2 		$174M Buy
550,344
+61,724
+13% +$18.6M 0.26% 77
2014
Q1 		$149K Buy
488,620
+30,902
+7% +$9.81M 0.24% 91
2013
Q4 		$128K Sell
457,718
-4,139
-0.9% -$1.07M 0.2% 92
2013
Q3 		$111K Buy
461,857
+28,669
+7% +$6.42M 0.19% 96
2013
Q2 		$93.2M Buy
+433,188
New +$92.6M 0.18% 111

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s BIIB Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Biogen (BIIB) stake by 10% in Q1 2026, selling an estimated $1.96M and leaving 95,108 shares worth $17.4M. The position accounts for 0.02% of the portfolio, ranked #648.

Manulife (Manufacturers Life Insurance) first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $258M in Q3 2018. 1,005 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 95,108 shares of Biogen worth $17.4M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 10,628 Biogen shares in Q1 2026, an estimated $1.96M.
  • Biogen made up 0.02% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #648 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Biogen position peaked at $258M in Q3 2018.
  • 1,005 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.